Statistics for Heidelberg Pharma AG (id:2810 HPHA)

Valuation metrics

Market cap

106.26M

Enterprise value

65.68M

Trailing P/E (ttm)

-5.07

Forward P/E

-4.96

PEG ratio

-4.96

Price/Sales (ttm)

12.54

Price/Book (mrq)

2.85

Enterprise Value/Revenue

7.75

Enterprise Value/EBITDA

-3.11

Overview

Shares outstanding

46.60M

Float

8.64M

Shares short

% Held by insiders

0.81%

% Held by institutions

0.01%

Average volume (10 days)

8.12K

Average volume (90 days)

Price summary

52-Week low

2.17

52-Week high

4.07

52-Week change

-27.06%

Beta

-0.36

50-Day moving average

2.47

200-Day moving average

2.75

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

July 18th, 2014

Financials

Fiscal year

Fiscal year ends

November 30th, 2023

Most recent quarter (mrq)

August 31th, 2024

Profitability

Profit margin

-221.51%

Operating margin

-603.97%

Operational effectiveness

Return on assets

-19.45%

Return on equity

-42.99%

Income statement

Revenue (ttm)

0.18

Revenue per share (ttm)

0.18

Quarterly revenue growth (yoy)

Gross profit (ttm)

6.61M

EBITDA

-21,095,890.00

Net income to common (ttm)

-18,766,690.00

Diluted EPS (ttm)

-0.41

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

36.57M

Total cash per share (mrq)

0.82

Total debt (mrq)

159.22K

Total Debt/Equity (mrq)

0.44

Current ratio (mrq)

600.60%

Book value per share (mrq)

0.80

Cash flow

Cash flow statement

-29,926,508.00

Levered free cash flow (LFCF)

-23,428,924.00